BioWorld Science

Feb. 22, 2007

View Archived Issues

Recent Tibotec, Medivir and Valeant patents report novel anti-hepatitis agents

Read More

Medivir reviews 2006

Read More

Studies detail stem cell mobilization efficacy of AMD-3100

Read More

Association between dopamine agonist use and pathological gambling in RLS

Read More

Novel anticancer compounds described in recent patents

Read More

Novel therapeutic agents for respiratory disorders described in recent patents

Read More

Novel therapeutic agents for transplant rejection disclosed by Astellas

Read More

New vaccine therapy may be useful to treat recurrent cancer in the elderly

Read More

Noscapine shows efficacy in prostate cancer

Read More

Genfit renews alliances

Read More

Schering-Plough begins phase I study of Pharmacopeia collaborative compound

Read More

Avalon begins drug discovery program targeting MYC oncoprotein

Read More

Treatment begins in pivotal program for LX-211 in uveitis

Read More

Shire to acquire New River Pharmaceuticals

Read More

Disruption of the CXCR4-CXCL12 and VLA4-VCAM-1 axes may sensitize leukemia cells to chemotherapy

Read More

Bentley cleared to begin phase II program for Nasulin in India

Read More

Athenagen changes name to CoMentis

Read More

MIST-B02 shows promise in pilot pharmacokinetic study

Read More

Hana anticipates delay in launch of Zensana

Read More

AA-4500 successful in treating Dupuytren's contracture

Read More

6R-BH4 shows no significant benefit over placebo in poorly controlled hypertension

Read More

SD-118 for neuropathic pain completes preclinical testing

Read More

Vascular disruption agent BNC-105 begins safety studies in animals

Read More

Allon files IND for AL-108 phase II trials in schizophrenia

Read More

FDA requests strengthened label warnings for Xolair

Read More